Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P McAdoo

Showing results (71-80 of 104) with videos related to

Pageof 11
Sort By:
Annals of the Rheumatic Diseases|August 7, 2021
Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppressionMaria Prendecki, Candice Clarke, Helena Edwards, et al.
The Lancet Regional Health. Europe|September 15, 2022
Comparison of immunogenicity and clinical effectiveness between BNT162b2 and ChAdOx1 SARS-CoV-2 vaccines in people with end-stage kidney disease receiving haemodialysis: A prospective, observational cohort studyPaul Martin, Sarah Gleeson, Candice L Clarke, et al.
Scientific Reports|March 1, 2022
Inhibition of spleen tyrosine kinase decreases donor specific antibody levels in a rat model of sensitizationShenzhen Tempest-Roe, Maria Prendecki, Stephen P McAdoo, et al.
Cell Reports|July 11, 2019
Acute Iron Deprivation Reprograms Human Macrophage Metabolism and Reduces Inflammation In VivoMarie Pereira, Tai-Di Chen, Norzawani Buang, et al.
Rheumatology (Oxford, England)|December 11, 2024
A protocol for targeted B-lymphocyte depletion for the treatment of IgG4-related diseaseMatthew Colquhoun, Tara D Barwick, Eva Bolton, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 26, 2022
Syk Activation in Circulating and Tissue Innate Immune Cells in Antineutrophil Cytoplasmic Antibody-Associated VasculitisMaria Prendecki, Kavita Gulati, Noelle Pisacano, et al.
The Lancet. Rheumatology|January 22, 2024
Antibody prevalence after three or more COVID-19 vaccine doses in individuals who are immunosuppressed in the UK: a cross-sectional study from MELODYFiona A Pearce, Sean H Lim, Mary Bythell, et al.
Frontiers in Immunology|May 17, 2021
Plasma Lectin Pathway Complement Proteins in Patients With COVID-19 and Renal DiseaseNicholas R Medjeral-Thomas, Anne Troldborg, Annette G Hansen, et al.
Lancet (London, England)|October 7, 2021
Immunological responses to SARS-CoV-2 vaccines in kidney transplant recipientsMaria Prendecki, Tina Thomson, Candice L Clarke, et al.
Lancet (London, England)|January 25, 2025
Impact of SARS-CoV-2 spike antibody positivity on infection and hospitalisation rates in immunosuppressed populations during the omicron period: the MELODY studyLisa Mumford, Rachel Hogg, Adam Taylor, et al.
Pageof 11

Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
Annals of the Rheumatic Diseases|August 7, 2021
Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppressionMaria Prendecki, Candice Clarke, Helena Edwards, et al.
The Lancet Regional Health. Europe|September 15, 2022
Comparison of immunogenicity and clinical effectiveness between BNT162b2 and ChAdOx1 SARS-CoV-2 vaccines in people with end-stage kidney disease receiving haemodialysis: A prospective, observational cohort studyPaul Martin, Sarah Gleeson, Candice L Clarke, et al.
Scientific Reports|March 1, 2022
Inhibition of spleen tyrosine kinase decreases donor specific antibody levels in a rat model of sensitizationShenzhen Tempest-Roe, Maria Prendecki, Stephen P McAdoo, et al.
Cell Reports|July 11, 2019
Acute Iron Deprivation Reprograms Human Macrophage Metabolism and Reduces Inflammation In VivoMarie Pereira, Tai-Di Chen, Norzawani Buang, et al.
Rheumatology (Oxford, England)|December 11, 2024
A protocol for targeted B-lymphocyte depletion for the treatment of IgG4-related diseaseMatthew Colquhoun, Tara D Barwick, Eva Bolton, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 26, 2022
Syk Activation in Circulating and Tissue Innate Immune Cells in Antineutrophil Cytoplasmic Antibody-Associated VasculitisMaria Prendecki, Kavita Gulati, Noelle Pisacano, et al.
The Lancet. Rheumatology|January 22, 2024
Antibody prevalence after three or more COVID-19 vaccine doses in individuals who are immunosuppressed in the UK: a cross-sectional study from MELODYFiona A Pearce, Sean H Lim, Mary Bythell, et al.
Frontiers in Immunology|May 17, 2021
Plasma Lectin Pathway Complement Proteins in Patients With COVID-19 and Renal DiseaseNicholas R Medjeral-Thomas, Anne Troldborg, Annette G Hansen, et al.
Lancet (London, England)|October 7, 2021
Immunological responses to SARS-CoV-2 vaccines in kidney transplant recipientsMaria Prendecki, Tina Thomson, Candice L Clarke, et al.
Lancet (London, England)|January 25, 2025
Impact of SARS-CoV-2 spike antibody positivity on infection and hospitalisation rates in immunosuppressed populations during the omicron period: the MELODY studyLisa Mumford, Rachel Hogg, Adam Taylor, et al.
Pageof 11